Omecamtiv Mecarbil

DB11816InvestigationalSmall molecule

Omecamtiv Mecarbil has been used in trials studying the treatment and basic science of Heart Failure, Echocardiogram, Pharmacokinetics, Chronic Heart Failure, and History of Chronic Heart Failure, among others.

Chemical structure of Omecamtiv Mecarbil
Formula / weight
C20H24FN5O3 · 401.442 g/mol (avg)
Code names
CK-1827452

Resolves to

Compound
UNII2M19539ERKCAS873697-71-3ChEMBLCHEMBL1800955PubChem11689883
Clinical / RWD
ATCC01CX10
Structure
InChIKeyRFUBTTPMWSKEIW-UHFFFAOYSA-NSMILESCOC(=O)N1CCN(CC2=C(F)C(NC(=O)NC3=CC=C(C)N=C3)=CC=C2)CC1
Targets
Q14896MYBPC3

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
13Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 3 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Omecamtiv Mecarbil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In